🏥 治験ポータル
← 治験一覧に戻る

前立腺癌に対する標的マイクロ波組織凝固療法

基本情報

NCT ID
NCT06430749
ステータス
募集中
試験のフェーズ
該当なし
試験タイプ
介入
目標被験者数
65
治験依頼者名
Kyoto Prefectural University of Medicine

概要

This clinical trial is to provide a minimally invasive treatment option in which the targeted prostate cancer tissue is killed by microwave only in the specific area of cancer "that should be treated for saving of life," while leaving a portion of the normal prostate tissue that is not cancerous. This treatment is named "focal therapy" for "clinically localized prostate cancer." As this new treatment aims to treat only the specific prostatic area of cancer, it is different from the invasive conventional treatment to remove the entire prostate gland. The goal is both to control the known cancer by treating only the cancerous area and to maintain the quality of life (QOL) by leaving the other normal prostate tissue and its surrounding organs intact, resulting in the prevention of urinary leakage and sexual dysfunction as complications.

対象疾患

Prostate Cancer

介入

Microtaze(DEVICE)

依頼者(Sponsor)

実施施設 (1)

京都府立医科大学附属病院

Kyoto, Japan(RECRUITING)